Related Experiment Video
Updated: May 9, 2026

Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
Published on: April 1, 2018
Evaluation of Orexin-A, Adiponectin and Apelin-13 Serum Levels in Children Diagnosed With Attention Deficit
Serdar Avunduk1, Ömer Başay2, Süleyman Demir3
1Child and Adolescent Psychiatry, Balıkesir Atatürk City Hospital, Balıkesir, Turkey.
Insights
Attention deficit hyperactivity disorder (ADHD) in children may be linked to lower adiponectin (HMWA) levels. This study found no significant differences in orexin-a or apelin-13 serum levels in children with ADHD.
Area of Science:
- Neuroscience
- Pediatrics
- Biochemistry
Background:
- Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder with complex and unclear etiopathogenesis.
- Neuropathological, genetic, and environmental factors are implicated in ADHD development.
Purpose of the Study:
- To investigate the serum levels of orexin-a, adiponectin (high molecular weight adiponectin - HMWA), and apelin-13 in the context of ADHD etiopathogenesis.
- To explore potential correlations between these biomarkers and ADHD symptoms.
Main Methods:
- Serum samples from 37 children with ADHD and 35 healthy controls (aged 6-18) were analyzed using ELISA for orexin-a, adiponectin (HMWA), and apelin-13.
- ADHD symptoms were evaluated using DSM-5 criteria, Conners Scales, and the Wisconsin Card Sorting Test.
Main Results:
- No significant differences in serum orexin-a and apelin-13 levels were observed between ADHD and control groups.
- A statistically significant reduction in adiponectin (HMWA) levels was found in preadolescent children (aged 6-11) with ADHD compared to controls, even after adjusting for age and BMI.
- No correlation was found between orexin-a, apelin-13, or adiponectin levels and ADHD symptom severity or cognitive performance on the Wisconsin Card Sorting Test.
Conclusions:
- Serum levels of orexin-a and apelin-13 do not appear to be significantly correlated with ADHD.
- Decreased serum adiponectin (HMWA) concentrations may be associated with ADHD in preadolescent children.
- Further research is warranted to elucidate the role of adiponectin in ADHD pathophysiology.
Objective:
This study investigates the role of orexin-a, adiponectin (HMWA) and apelin-13 serum levels in the etiopathogenesis of attention deficit hyperactivity disorder (ADHD), a neurodevelopmental disorder with unclear aetiology involving neuropathological, genetic and environmental factors.
Methods:
The study involved 37 children with ADHD and 35 healthy controls, aged 6-18 years, with no history of other physical or psychiatric illnesses and no psychotropic medication use in the last 6 months. Serum levels of orexin-a, adiponectin (HMWA) and apelin-13 were measured using enzyme-linked immunosorbent assay (ELISA). ADHD symptoms were assessed through Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5)-based clinical interviews, Conners Parent and Teacher Rating Scales and Wisconsin Card Sorting Test.
Results:
No significant differences in serum orexin-a, adiponectin (HMWA) and apelin-13 levels were found between the ADHD and control groups. Additionally, there was no relationship between orexin-a, apelin-13 and adinopectin levels and ADHD symptoms and Wisconsin Card Sorting Test results. Analysis of adiponectin levels in preadolescent children aged 6-11, adjusting for age and BMI, revealed a statistically significant reduction in the ADHD group (p = 0.002).
Conclusion:
The results did not demonstrate any correlation between ADHD and the levels of orexin-a and apelin-13. However, the study revealed that children with ADHD, aged 6-11, exhibited decreased adiponectin concentrations. These results suggest that a decrease in serum adinopectin levels may be associated with ADHD in children.
More Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
10:02Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Published on: March 12, 2020
Related Concept Videos
Regulation of Food Intake
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.